
COVID-19 Pandemic Prompts Federal Agencies to Reduce Restrictions on Medications for Opioid Use Disorder
Law & Policy InsightsCOVID-19Substance Use Prevention and Harm ReductionHarm Reduction Legal ProjectTelehealthThe medications methadone and buprenorphine are extremely effective in reducing the harms associated with opioid use disorder. In light of the ongoing public health emergency associated with COVID-19 the federal government has recently taken a number of steps to increase access to these lifesaving medications.